Blood clot, or venous thromboembolism (VTE), occurs for the first time in about 100 people per 100,000 each year in the United States. Blood clots that develop during a hospital stay are often associated with poorer clinical outcomes and prolonged hospital stays.
The Michigan Hospital Medicine Safety Consortium was created in 2010 to improve care of medical patients at risk for hospital associated VTEs. Hospitalists and 51 Michigan hospitals are evaluating best practices for drug-based blood clot prevention, and developing strategies to improve these practices.
For more information, go to mi-hms.org
The Hospital Medicine Safety consortium has used a validated identification process for appropriate candidates for VTE prophylaxis. This process is challenging national standards and has been recognized by the Society of Hospital Medicine as one of the top three developments in hospital medicine.
- There has been a statistically significant improvement in the rates of pharmacologic prophylaxis for high risk patients without complications.
- Participating sites showed a 35 percent improvement in patients receiving a risk assessment for potential VTE.
- There is a 36 percent increase in the amount of high risk patients who had mechanical prophylaxis ordered (based on the Padua risk assessment model to define high risk patients).
- For the PICC Use Initiative, baseline data is still being collected by most member hospitals, but improvement is beginning to be seen in the initiative goals.